GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Core One Labs Inc (OTCPK:CLABF) » Definitions » Operating Margin %

CLABF (Core One Labs) Operating Margin % : -455.71% (As of Dec. 2023)


View and export this data going back to 2015. Start your Free Trial

What is Core One Labs Operating Margin %?

Operating Margin % is calculated as Operating Income divided by its Revenue. Core One Labs's Operating Income for the three months ended in Dec. 2023 was $-0.32 Mil. Core One Labs's Revenue for the three months ended in Dec. 2023 was $0.07 Mil. Therefore, Core One Labs's Operating Margin % for the quarter that ended in Dec. 2023 was -455.71%.

The historical rank and industry rank for Core One Labs's Operating Margin % or its related term are showing as below:


CLABF's Operating Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -117.725
* Ranked among companies with meaningful Operating Margin % only.

Core One Labs's 5-Year Average Operating Margin % Growth Rate was 0.00% per year.

Core One Labs's Operating Income for the three months ended in Dec. 2023 was $-0.32 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.93 Mil.


Core One Labs Operating Margin % Historical Data

The historical data trend for Core One Labs's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Core One Labs Operating Margin % Chart

Core One Labs Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Operating Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -6,771.33 -275.37 - - -2,822.49

Core One Labs Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Sep23 Dec23
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1,132.08 -924.71 -828.06 -1,182.69 -455.71

Competitive Comparison of Core One Labs's Operating Margin %

For the Biotechnology subindustry, Core One Labs's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Core One Labs's Operating Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Core One Labs's Operating Margin % distribution charts can be found below:

* The bar in red indicates where Core One Labs's Operating Margin % falls into.


;
;

Core One Labs Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Core One Labs's Operating Margin % for the fiscal year that ended in Dec. 2021 is calculated as

Operating Margin %=Operating Income (A: Dec. 2021 ) / Revenue (A: Dec. 2021 )
=-9.54 / 0.338
=-2,822.49 %

Core One Labs's Operating Margin % for the quarter that ended in Dec. 2023 is calculated as

Operating Margin %=Operating Income (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=-0.319 / 0.07
=-455.71 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Core One Labs  (OTCPK:CLABF) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Core One Labs Operating Margin % Related Terms

Thank you for viewing the detailed overview of Core One Labs's Operating Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Core One Labs Business Description

Traded in Other Exchanges
N/A
Address
1199 West Hastings Street, Suite 800, Vancouver, BC, CAN, V6E 3T5
Core One Labs Inc is a psychedelic research and development life sciences enterprise focused on bringing psychedelic medicines to market through novel delivery systems and psychedelic assisted psychotherapy. The company intends to further develop and apply the technology to psychedelic compounds, such as psilocybin. The Company operates a virtual clinic that assesses patients for the appropriateness of treatment plans for the use of medical cannabis to treat their symptoms. The Company partners with physicians and Health Canada's licensed producers for the provision of treatments, fulfillment of prescriptions, and sale of related products.

Core One Labs Headlines

From GuruFocus

Core One in Talks with Multiple Companies to Supply Psilocybin

By ACCESSWIRE ACCESSWIRE 05-06-2023

Core One Labs' Upgrades to OTCQB Venture Market

By GuruFocusNews GuruFocusNews 04-06-2022